Monday, April 3, 2017

Roche Subsidiary Genentech Wins FDA Approval for MS Treatment Ocrevus | GEN Genetic Engineering & Biotechnology News - Biotech from Bench to Business | GEN

Genentech Wins FDA Approval for MS Treatment Ocrevus | GEN Genetic Engineering & Biotechnology News - Biotech from Bench to Business | GEN


















Roche Holding AG ADR (OTC:RHHBY)

No comments: